Titan Pharmaceuticals Inc (TTNP)
6.82
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
6.82
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.061M |
| September 30, 2022 | 0.014M |
| June 30, 2022 | 0.05M |
| March 31, 2022 | 0.492M |
| December 31, 2021 | 1.171M |
| September 30, 2021 | 2.612M |
| June 30, 2021 | 3.59M |
| March 31, 2021 | 4.394M |
| December 31, 2020 | 4.838M |
| September 30, 2020 | 3.604M |
| June 30, 2020 | 3.533M |
| March 31, 2020 | 2.786M |
| December 31, 2019 | 2.605M |
| September 30, 2019 | 3.631M |
| June 30, 2019 | 4.334M |
| March 31, 2019 | 6.50M |
| December 31, 2018 | 6.619M |
| September 30, 2018 | 5.44M |
| June 30, 2018 | 3.83M |
| March 31, 2018 | 1.239M |
| December 31, 2017 | 0.215M |
| September 30, 2017 | 0.192M |
| June 30, 2017 | 0.178M |
| March 31, 2017 | 15.10M |
| December 31, 2016 |
| Date | Value |
|---|---|
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 3.494M |
| March 31, 2015 | 3.645M |
| December 31, 2014 | 3.645M |
| September 30, 2014 | 3.644M |
| June 30, 2014 | 4.931M |
| March 31, 2014 | 6.218M |
| December 31, 2013 | 10.48M |
| September 30, 2013 | 12.83M |
| June 30, 2013 | 11.86M |
| March 31, 2013 | 11.02M |
| December 31, 2012 | 7.117M |
| September 30, 2012 | 5.271M |
| June 30, 2012 | 5.055M |
| March 31, 2012 | 4.39M |
| December 31, 2011 | 4.068M |
| September 30, 2011 | 5.381M |
| June 30, 2011 | 7.969M |
| March 31, 2011 | 8.616M |
| December 31, 2010 | 10.09M |
| September 30, 2010 | 7.394M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.014M
Minimum
Sep 2022
4.838M
Maximum
Dec 2020
2.514M
Average
2.786M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Outset Medical Inc | 130.38M |
| Allurion Technologies Inc | 53.47M |
| AIM ImmunoTech Inc | 0.202M |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |